369 related articles for article (PubMed ID: 25516638)
1. Locally advanced rectal cancer: the importance of a multidisciplinary approach.
Berardi R; Maccaroni E; Onofri A; Morgese F; Torniai M; Tiberi M; Ferrini C; Cascinu S
World J Gastroenterol; 2014 Dec; 20(46):17279-87. PubMed ID: 25516638
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiation in locally advanced rectal cancer: the surgeon's perspective.
Azin A; Khorasani M; Quereshy FA
J Clin Pathol; 2019 Feb; 72(2):133-134. PubMed ID: 30670565
[No Abstract] [Full Text] [Related]
3. Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.
Berardi R; Maccaroni E; Onofri A; Giampieri R; Bittoni A; Pistelli M; Scartozzi M; Pierantoni C; Bianconi M; Cascinu S
Expert Opin Pharmacother; 2009 Oct; 10(14):2245-58. PubMed ID: 19640208
[TBL] [Abstract][Full Text] [Related]
4. Advances and challenges in treatment of locally advanced rectal cancer.
Smith JJ; Garcia-Aguilar J
J Clin Oncol; 2015 Jun; 33(16):1797-808. PubMed ID: 25918296
[TBL] [Abstract][Full Text] [Related]
5. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
6. Role of combined-modality therapy in the management of locally advanced rectal cancer.
Hosein PJ; Rocha-Lima CM
Clin Colorectal Cancer; 2008 Nov; 7(6):369-75. PubMed ID: 19036689
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
Ide S; Toiyama Y; Okugawa Y; Oki S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Kusunoki M
Anticancer Res; 2017 Oct; 37(10):5797-5804. PubMed ID: 28982904
[TBL] [Abstract][Full Text] [Related]
8. Why is neoadjuvant chemoradiation therapy underused for locally advanced rectal cancer?
Molinari C; Passardi A
Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1317-1319. PubMed ID: 27754713
[No Abstract] [Full Text] [Related]
9. Delay to Adjuvant Chemotherapy: Survival and Recurrence in Patients of Rectal Cancer Treated with Neo-adjuvant Chemoradiotherapy and Surgery.
Thong DW; Kim J; Naik A; Lu CT; Nolan GJ; Von Papen M
J Gastrointest Cancer; 2020 Sep; 51(3):877-886. PubMed ID: 31691086
[TBL] [Abstract][Full Text] [Related]
10. Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades.
Wiegering A; Isbert C; Dietz UA; Kunzmann V; Ackermann S; Kerscher A; Maeder U; Flentje M; Schlegel N; Reibetanz J; Germer CT; Klein I
BMC Cancer; 2014 Nov; 14():816. PubMed ID: 25376382
[TBL] [Abstract][Full Text] [Related]
11. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
[TBL] [Abstract][Full Text] [Related]
12. [Rectal cancer: current status of multimodal therapy--when and how?].
Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Transanal Local Excision Following Chemoradiation for Lower Rectal Cancer.
Tokunaga T; Nishi M; Higashijima J; Yoshikawa K; Kashihara H; Takasu C; Ishikawa D; Bando Y; Shimada M
Anticancer Res; 2017 Oct; 37(10):5617-5622. PubMed ID: 28982878
[TBL] [Abstract][Full Text] [Related]
14. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
Fan J; Zhu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.
Park IJ; You YN; Agarwal A; Skibber JM; Rodriguez-Bigas MA; Eng C; Feig BW; Das P; Krishnan S; Crane CH; Hu CY; Chang GJ
J Clin Oncol; 2012 May; 30(15):1770-6. PubMed ID: 22493423
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiation of rectal cancer.
Arrazubi V; Suárez J; Novas P; Pérez-Hoyos MT; Vera R; Martínez Del Prado P
Minerva Chir; 2013 Feb; 68(1):11-26. PubMed ID: 23584263
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study.
Sorrentino L; Guaglio M; Battaglia L; Bonfanti G; Vitellaro M; Bianchi AC; Milione M; Belli F
Int J Colorectal Dis; 2019 Dec; 34(12):2161-2169. PubMed ID: 31741026
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
Yu BM; Zhang M; Wu WQ; Chen LW; Fu J; Fei CS; Shen Y
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):445-8. PubMed ID: 17686297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
